Institutes for Systems Genetics, West China Hospital
Copyright @ 2023 ISG. All Rights Reserved.
Group name
Intermediate-risk
Groups definition
intermediate-risk defined as having at least one characteristic among clinical stage T2b-c or GS of 7 or PSA level of 10 to 20 ng/mL, and 95 patients were classified as high-risk defined as having at least one characteristic among clinical stage ≥ T3a or GS ≥8 or PSA level ≥20 ng/mL, according to the National Comprehensive Cancer Network (NCCN) classification
T1
51 (32.9)
T2
104 (67.1)
T3
0 (0)
Institutes for Systems Genetics, West China Hospital
Copyright @ 2023 ISG. All Rights Reserved.